DVA vs DXR · P/E 14, rev $6.97B vs P/E 6.5, rev $1.4M
DaVita HealthCare Partners Inc (DVA) versus Daxor Corporation (DXR) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Daxor Corporation (DXR) is a medical instruments & supplies company listed on US.
Latest reported DVA revenue for 2026-06-30 was $6.97B. Net income was $462.9M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported DXR revenue for 2011-12-31 was $1.4M. Net income was -$7.2M. Revenue was down 8.4% from 2010-12-31 to 2011-12-31. DXR currently screens at market cap $61.9M and trailing P/E 6.5.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. DXR currently screens at market cap $61.9M and trailing P/E 6.5.
Not investment advice. Open the DVA and DXR stock pages for the full models.
Not investment advice.